NCT03526133View on ClinicalTrials.gov

Validation of Sleep Apnea Diagnosis Device

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

July 7, 2017

Primary Completion Date

December 7, 2018

Study Completion Date

February 7, 2019

Conditions
Sleep Apnea
Interventions
DIAGNOSTIC_TEST

Polysomnography (PSG) and wireless sensor Oxistar

Monitoring the apnea-hypopnea index (AHI) derived from PSG and the oxygen desaturation index (ODI) obtained by the Oxistar.

Trial Locations (1)

05403-900

Incor - Heart Institute, Sleep Laboratory, São Paulo

All Listed Sponsors
collaborator

Biologix Sistemas Ltda

UNKNOWN

lead

University of Sao Paulo General Hospital

OTHER

NCT03526133 - Validation of Sleep Apnea Diagnosis Device | Biotech Hunter | Biotech Hunter